Thomas Hofmarcher

About Thomas Hofmarcher

Thomas Hofmarcher, With an exceptional h-index of 9 and a recent h-index of 8 (since 2020), a distinguished researcher at Lunds Universitet, specializes in the field of Health Economics, Labor Economics, Cancer policy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Tackling inequalities in cancer care in the European Union

Societal costs of illegal drug use in Sweden

The Disease Burden and Economic Burden of Cancer in 9 Countries in the Middle East and Africa

Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefit

A global analysis of the value of precision medicine in oncology–The case of non-small cell lung cancer

Samhällets kostnader för spelproblem i Sverige 2021–En uppdatering

Improving the care of women with triple-negative breast cancer

Värdet av tidig behandling av cancer med immunterapi i Sverige–En genomgång av litteraturen

Thomas Hofmarcher Information

University

Position

Department of Economics

Citations(all)

740

Citations(since 2020)

652

Cited By

229

hIndex(all)

9

hIndex(since 2020)

8

i10Index(all)

9

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Thomas Hofmarcher Skills & Research Interests

Health Economics

Labor Economics

Cancer policy

Top articles of Thomas Hofmarcher

Tackling inequalities in cancer care in the European Union

2024

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Societal costs of illegal drug use in Sweden

International Journal of Drug Policy

2024/1/1

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Joakim Strandberg
Joakim Strandberg

H-Index: 10

The Disease Burden and Economic Burden of Cancer in 9 Countries in the Middle East and Africa

Value in Health Regional Issues

2023/9/1

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefit

ESMO open

2023/8/1

A global analysis of the value of precision medicine in oncology–The case of non-small cell lung cancer

Frontiers in Medicine

2023/2/20

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Samhällets kostnader för spelproblem i Sverige 2021–En uppdatering

2023

Anna Gustafsson
Anna Gustafsson

H-Index: 6

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Improving the care of women with triple-negative breast cancer

2023

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Värdet av tidig behandling av cancer med immunterapi i Sverige–En genomgång av litteraturen

2023

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

EE510 A Global Analysis of the Value of Precision Medicine in Oncology–The Case of Non-Small Cell Lung Cancer

Value in Health

2022/12/1

Systemic anti-cancer therapy patterns in advanced non-small cell lung cancer in Europe

Journal of Cancer Policy

2022/12/1

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Specialization in same-sex and different-sex couples

Labour Economics

2022/8/1

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Erik Plug
Erik Plug

H-Index: 17

Cancer in Ireland–Disease Burden, Costs and Access to Medicines

2022

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Samhällsekonomiska kostnader för narkotikabruk i Sverige

2022

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Diagnosed but not treated: How to improve patient access to advanced NSCLC treatment in Europe

2022

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Cancer Care in the Middle East and Africa

2021/11/24

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

The Porto European cancer research summit 2021

2021/10

1346P Diagnosed with non-small cell lung cancer but not treated

Annals of Oncology

2021/9/1

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

The effect of education on poverty: A European perspective

Economics of Education Review

2021/8/1

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

The effect of paid vacation on health: evidence from Sweden

Journal of Population Economics

2021/7

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

Cancer care and access to cancer drugs in Asia-Pacific

2021

Thomas Hofmarcher
Thomas Hofmarcher

H-Index: 6

See List of Professors in Thomas Hofmarcher University(Lunds Universitet)

Co-Authors

academic-engine